Jul 9, 2026 05:01PM
Jul 9, 2026 05:00PM
Jun 29, 2026 07:31AM
Jun 29, 2026 07:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM
May 27, 2026 07:31AM Biohaven reports positive patient data for autoimmune disease drugs
May 27, 2026 07:30AM
May 26, 2026 07:31AM
May 26, 2026 07:30AM
May 4, 2026 04:02PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 2, 2026 04:05PM Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
Feb 23, 2026 08:43AM
Jan 12, 2026 11:20AM
Jan 12, 2026 11:15AM
Jan 7, 2026 07:00AM
Dec 24, 2025 01:00PM
Dec 24, 2025 01:00PM
Dec 11, 2025 07:02AM Biohaven shares cancer drug trial results at European oncology meeting
Dec 11, 2025 07:00AM
Nov 17, 2025 07:38AM
Nov 11, 2025 04:29AM
Nov 10, 2025 06:58AM
Nov 6, 2025 08:37AM
Nov 5, 2025 04:09PM
Nov 5, 2025 03:33PM BofA Securities Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral
Nov 5, 2025 10:00AM
Nov 5, 2025 08:20AM
Nov 5, 2025 08:19AM
Nov 5, 2025 08:17AM
Nov 5, 2025 08:16AM
Nov 5, 2025 06:10AM
Nov 5, 2025 01:56AM FDA rejects Biohaven drug application for rare brain disorder
Nov 4, 2025 08:06PM
Nov 3, 2025 10:00AM
Nov 3, 2025 09:24AM
Sep 10, 2025 09:16AM
Aug 30, 2025 04:00PM
Aug 22, 2025 07:04AM
Aug 19, 2025 05:05AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at BTIG
Aug 12, 2025 06:41AM
Aug 11, 2025 07:00AM
Jul 22, 2025 05:52PM
Jul 20, 2025 10:50AM
Jun 28, 2025 10:00AM
Jun 23, 2025 12:47PM
Jun 18, 2025 12:21PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
Jun 15, 2025 10:00AM

325,464 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All